NanoBio Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
NanoBio Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         NanoBio Corporation - Pharmaceuticals & Healthcare - Deals and Alliances
                                        Profile
       Reference Code: GDPH138369D                                                                                                            Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      NanoBio Corporation (NanoBio) is a biopharmaceutical company based in the US.
                                                                                                              NanoBio Corporation, Pharmaceuticals &
      The company develops and commercializes novel products for the prevention and
                                                                                                              Healthcare, Key Facts
      treatment of infectious diseases. It researches and develops operations for the
      development of drugs and vaccines for dermatological conditions, infectious disease                      Web Address                        www.nanobio.com
      and other therapeutic indications. NanoBio develops its products based on its
                                                                                                               Revenue (US$ million)                             NA
      proprietary NanoStat development platform that facilitates the development of
      topical anti-infective products and an array of mucosal vaccines. The company has                        Number of Employees                               NA
      Strategic Alliances with companies which include, Merck & Co., Inc., Bill & Melinda                      GlobalData
      Gates Foundation and The National Institute of Health.

      Financial Deals Landscape
        NanoBio Corporation, Pharmaceuticals & Healthcare, Deals by                       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                                    2             2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                          1                                1
                                                                                                          1


                                                                                                                 0                        0                          0
                                                                                                          0
                                                                                                               2007      2008   2009     2010    2011     2012   YTD
                                                                                                                                                                 2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         NanoBio Corporation, Pharmaceuticals & Healthcare, Deals                         NanoBio Corporation, Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         8                                                                                6
                               6                                                                                     5
          No. of Deals




                                                                                                          5
                                                                                           No. of Deals




                         6
                                                                                                          4
                         4                                                                                                      3
                                                                                                          3
                         2                                                                                                                2           2
                                        0         0        0         0                                    2
                                                                                                                                                                 1
                         0
                                                                                                          1
                             North    Asia-     Europe   Middle   South
                             Americ   Pacific             East     and                                    0
                               a                          and     Central                                       Infectio Dermat         Oncolo    Respira Immun
                                                         Africa   Americ                                           us     ology           gy       tory    ology
                                                                    a                                           Disease



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




NanoBio Corporation - Pharmaceuticals & Healthcare - Deals and                                                                                   Reference Code: GDPH138369D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                 Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................ 3
       NanoBio Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013................................................................. 5
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 6
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................................. 7
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................................. 8
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deal Details................................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             NanoBio Raises $11 Million In Series C Financing ..................................................................................................................... 9
             NanoBio Raises $22 Million In Series B Round Of Financing ................................................................................................... 10
             NanoBio Secures $10 Million In Final Tranche Of Financing .................................................................................................... 12
          Licensing Agreements .................................................................................................................................................................. 13
             NanoBio Enters Into Licensing Agreement With National Institutes Of Health .......................................................................... 13
             NanoBio Enters Into Licensing Agreement With University Of Michigan ................................................................................... 14
             GlaxoSmithKline Enters Into Licensing Agreement With NanoBio ............................................................................................ 15
       NanoBio Corporation - Key Competitors .......................................................................................................................................... 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       Appendix .......................................................................................................................................................................................... 19
          Methodology ................................................................................................................................................................................. 19
          About GlobalData ......................................................................................................................................................................... 19
          Contact Us .................................................................................................................................................................................... 19
          Disclaimer ..................................................................................................................................................................................... 19




NanoBio Corporation - Pharmaceuticals & Healthcare - Deals and                                                                                                   Reference Code: GDPH138369D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       NanoBio Corporation, Pharmaceuticals & Healthcare, Key Facts ...................................................................................................... 1
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................ 1
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 1
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................................. 1
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................ 4
       NanoBio Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013................................................................. 5
       NanoBio Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................ 6
       NanoBio Corp
				
DOCUMENT INFO
Description: NanoBio Corporation (NanoBio) is a biopharmaceutical company based in the US. The company develops and commercializes novel products for the prevention and treatment of infectious diseases. It researches and develops operations for the development of drugs and vaccines for dermatological conditions, infectious disease and other therapeutic indications. NanoBio develops its products based on its proprietary NanoStat development platform that facilitates the development of topical anti-infective products and an array of mucosal vaccines. The company has Strategic Alliances with companies which include, Merck & Co., Inc., Bill & Melinda Gates Foundation and The National Institute of Health. NanoBio is headquartered in Ann Arbor, Michigan, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.